Is Now the Time to Buy AstraZeneca PLC?
Published: Nov 30, 2012
I'm always searching for shares that can help ordinary investors like you make money from the stock market. So right now I am trawling through the FTSE 100 and giving my verdict on every member of the blue-chip index. Simply put, I'm hoping to pinpoint the very best buying opportunities in today's uncertain market. Today I am looking at AstraZeneca (LSE: AZN ) (NYSE: AZN ) to determine whether you should consider buying the shares at 2,930 pence. Trading on a projected P/E of 7.6, AstraZeneca looks cheaper than its peers in the Pharmaceutical & Biotech sector, which are currently trading on an average P/E of 11.4. However, AstraZeneca's P/E ratio and negative growth rate gives a PEG ratio of less than 0. With a negative result, the PEG ratio cannot help with my analysis.